In this cohort of postmenopausal breast cancer patients, 10.2% harbored pathogenic germline BRCA1/BRCA2 variants; 11.7% of these patients had at least one family member who was affected with breast, ovarian, prostate, or pancreatic cancer. Here, BRCA1 is linked to breast carcinoma.